Politics · United States · 2 hrs ago

US panel warns China is gaining ground in biopharmaceuticals

US panel warns China is gaining ground in biopharmaceuticals

A US congressional advisory body warned that China’s biopharmaceutical sector is rising quickly in its annual report, published on Thursday.

The report said China was gaining a competitive advantage in the field.

Western companies are paying large upfront fees to license Chinese drugs, which the panel linked to China’s growing ability to develop new medicines.

At a congressional hearing, commission member Leland Miller said China could become an innovation hub that might replace the United States.

The warning is adding to Washington’s push to curb cross-border ties in the sector.

Chinese biotech companies appear largely unfazed, while some experts have warned that plans to build up local industries could backfire.

1 source

Related